People · Operator
Named in public records as an officer, director or promoter · active 2022–2026 · Biotechnology, Software / Tech, Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ventaris Surgical, Inc. | — | Biotechnology | Series B | $30.7M | $114.0M | 2026 |
| Sea12 Technologies Inc. | — | Software / Tech | Series B | $24.9M | $103.7M | 2026 |
| Tea Inc. | — | Other Technology | Series A | $16.2M | $102.3M | 2022 |
| Ganymede Bio, Inc. | — | Biotech / Pharma | Series B | $15.2M | $238.6M | 2022 |
Varun Gupta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Varun Gupta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amir Abolfathi | 1 | 8 |
| Scott Walker | 1 | 7 |
| Justin Klein | 1 | 6 |
| Terren Peizer | 1 | 4 |
| Timothy Lewis | 1 | 4 |
| Troy Wong | 1 | 3 |
| Surag Mantri | 1 | 2 |
| Charles Englander | 1 | 2 |
| Benson Lee | 1 | 1 |
| Daniel Englander | 1 | 1 |
| Thomas Mosen | 1 | 1 |
| Matthew Sprinkel | 1 | 1 |
| Maxim Howell | 1 | 1 |
| Nathan Clark | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.